Skip to content
Screener

AdaptHealth AHCO Q1 2025 earnings

Reported May 6, 2025 · Before market open

Revenue$580.5MMiss by $227.7M
EPS$0.01In line
Revenue estimate$808.2M
EPS estimate$0.01

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$725.9M
EPS estimate-$0.05

Financials

Q1 2025

Income statement

See full
Revenue$777.9M-1.8%
Gross profit$120.4M-23.5%
Operating income$23.2M-54.1%
Net income-$7.2M-238%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$53.7M-32.6%
Total debt$2.1B-10.3%
Total equity$1.6B+7.3%
Total assets$4.4B-1.5%

Cash flow

See full
Operating cash flow$95.5M+94.8%
CapEx$95.6M+8.8%
Free cash flow-$58.0K+99.9%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.46B-4.4%
Enterprise value$3.51B-7.5%
P/E17.1×—
P/S0.5×0.0×

Profitability

See full
Gross margin19.8%-1.5pp
Operating margin7.3%+4.3pp
Net margin2.6%+1.4pp
FCF margin8.5%+6.8pp

Returns & leverage

See full
Return on equity5.6%+3.0pp
Debt / equity1.3×-0.3×
Current ratio1.3×0.0×

Segments

By segment

See full
Sleep Health$316.4M-2.8%
Respiratory Health$165.5M+3.3%
Wellness at Home$157.2M+0.7%
Diabetes Health$138.8M-8.0%

FAQ

When did AdaptHealth report Q1 2025 earnings?
AdaptHealth (AHCO) reported Q1 2025 earnings on May 6, 2025 before market open.
What were AdaptHealth's Q1 2025 revenue and EPS?
AdaptHealth reported revenue of $580.5M and eps of $0.01 for Q1 2025.
Did AdaptHealth beat estimates in Q1 2025?
Revenue missed the consensus estimate of $808.2M by $227.7M. EPS beat the consensus estimate of $0.01 by $0.00.
How did AdaptHealth's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 26.8% from $792.5M a year earlier and eps declined 50.0% from $0.02.
Where can I find AdaptHealth's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-022394) and the 10-Q periodic report (0001628280-25-022716) directly on SEC EDGAR. The filing index links above go to sec.gov.